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Running Title: Parametric Model of Flow and Extravasation in the Brain Vascular System  
Abstract: One of the key elements in Dynamic Contrast Enhanced (DCE) Image Analysis is the Arterial Input 
Function (AIF). Traditionally, in DCE studies a global AIF sampled from a major artery or vein is used for 
estimating the vascular permeability parameters; however, not addressing dispersion and delay of the AIF at the 
tissue level can lead to biased estimates of these parameters. To find less biased estimates of vascular permeability 
parameters, a vascular model of the cerebral vascular system is proposed that considers effects of dispersion of the 
Arterial Input Function (AIF) in the vessel branches, as well as extravasation of the contrast agent to the 
extravascular-extracellular space. Profiles of the contrast agent concentration were simulated for different 
branching levels of the vascular structure, combined with the effects of vascular leakage. To estimate the 
permeability parameters, the extended model was applied to these simulated signals and also to DCE-T1 (Dynamic 
Contrast Enhanced–T1) images of patients with Glioblastoma Multiforme tumors. The simulation study showed that 
compared to the case of solving the pharmacokinetic equation with a global AIF, using the local AIF that is 
corrected by the vascular model can give less biased estimates of the permeability parameters (Ktrans, vp and Kb). 
Applying the extended model to signals sampled from different areas of the DCE-T1 image showed that it is able to 
explain the contrast agent concentration profile both in the normal areas and the tumor area where effects of 
vascular leakage exist. Differences in the values of the permeability parameters estimated in these images using the 
local and global AIFs followed the same trend as the simulation study. These results demonstrate that the vascular 
model can be a useful tool for obtaining more accurate estimation of parameters in DCE studies. 
Keywords: 
Arterial Input Function, Vascular Modeling, Dynamic Contrast Enhanced Imaging, Vascular Permeability, Cerebral 
Tumors, DCE-MRI 
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Abbreviations:  
CA-Contrast Agent 
AIF- Arterial Input Function 
ASL - Arterial Spin Labeling  
DCE-CT - Dynamic Contrast Enhanced Computed Tomography 
DCE-MR - Dynamic Contrast Enhanced Magnetic Resonance 
DSC - Dynamic Susceptibility Contrast 
MTT - Mean Transit Time  
CBF - Cerebral Blood Flow 
CBV - Cerebral Blood Volume 
Ktrans -Vascular transfer rate constant 
vp- Vascular plasma volume  
kb- Inverse transfer rate constants  
ve - extracellular-extravascular space volume  
PET - Positron Emission Tomography  
AMM - Alternating Minimization with Model  
BVM - Basic Vascular Model  
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EM – Extended Model 
AIC - Akaike Information Criterion 
MRA - Magnetic Resonance Angiography  
SM - Standard Model  
DESPOT1 - Driven Equilibrium Single Pulse Observation of T1 
GBM - Glioblastoma Multiforme  
SPGRE – Spoiled Gradient Echo 
EES – Extravascular Extracellular Space 
CFD - Computational Fluid Dynamics  
 
INTRODUCTION 
One of the challenges in Dynamic Contrast Enhanced (DCE) studies is estimation of the time trace of local plasma 
Contrast Agent (CA) concentration or the Arterial Input Function (AIF) at the tissue level. We previously introduced 
a vascular transfer function of the brain that could model delay and dispersion of the CA concentration profile at 
different levels of the vascular branching tree. This transfer function is based on laws of fluid dynamics and vascular 
morphology. Previously, Gall et al (1) and Kellner et al (2) had used a similar approach and derived a vascular tree 
model to explain delay and dispersion of the Arterial Spin Labeling (ASL) bolus (3); they also used this model for 
estimating the residue function for brain tissue in perfusion measurements (4). These models assume that there is no 
leakage of the contrast agent to the extravascular-extracellular space. We used this transfer function to derive a 
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model and by applying it to DCE-CT images and using the estimated model parameters, created an arrival time map 
of the brain [**]. 
In the MRI field, Dynamic Susceptibility Contrast (DSC) Imaging is the method of choice for perfusion studies in 
which Mean Transit Time (MTT) , Cerebral Blood Flow (CBF) and Cerebral Blood Volume (CBV) are estimated 
(5); DSC is based on changes of the T2* signal in the dynamic images (6). In DCE-MRI studies, dynamic series of 
T1-weighted images are acquired and are mainly used for estimation of vascular permeability parameters such as 
vascular transfer rate constant (Ktrans), vascular plasma volume (vp), and extracellular-extravascular space (EES) 
volume (ve) (7-9).  Estimation of the permeability parameters can be done using pharmacokinetic models and one of 
these which is widely used is the Standard Model (SM) or Extended Tofts model (10). One of the main components 
in this model is the AIF. Theoretically this should be the local AIF that is sampled directly at the inlet to the tissue 
being studied; however, in practice usually the AIF sampled from a major artery is used (11) which results in 
eliminating the effects of dispersion and delay of the AIF (12). Inaccurate estimation of the AIF at the tissue level 
for use in permeability and perfusion analyses could substantially add bias to the estimated hemodynamic and 
permeability maps. Calamante et al used independent component analysis to show that delay and dispersion of the 
AIF can cause underestimation of the CBF and overestimation of the MTT in DSC studies (13). In their study, they 
showed that although the delay can be corrected using the information of the arrival time of the bolus to the tissue, 
correcting for the dispersion should be done using a vasculature model.  Lee et al used a model of tissue 
microcirculation based on tracer kinetics and Bayesian probability theory to estimate the localized AIF in DSC 
images and used that to estimate perfusion parameters (14); Permeability parameters found by employing these local 
AIFs showed strong correlation with those measured by quantitative Positron Emission Tomography (PET) with 
H2[15O].  
In the DCE-MR area, Fluckiger et al presented a method for blind estimation of the local AIF based on the 
Alternating Minimization with Model (AMM) method (15); to estimate the local AIF, they constrained it with a 
model containing three gamma-variate curves. Their results show that compared to using the local AIF, the current 
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method of using arterially measured AIFs biases the resulting parameters high, especially in regions where more 
dispersion of the AIF is expected. In one approach, to eliminate the need of direct AIF measurement, Yankeelov et 
al proposed a method for quantitative analysis of DCE-MRI by comparing the CA concentration profile of tissues of 
interest to that of a reference region. Using this method, Ktrans and ve were estimated but a validation of the final 
results was not performed (16). 
In this paper, to address the effects of extravasation, we extend our Basic Vascular Model (BVM) that we previously 
introduced [**] by combining it with the SM. Next, by simulating the AIF at different levels of the vascular system 
and also adding effects of vascular leakage to the simulated CA concentration profiles, we compare the results of 
using our model-corrected local AIF for estimating the permeability parameters with the Standard Model, to those 
estimated when using the global AIF. Finally we perform the same comparison using DCE-MR images of a patient 
with a cerebral tumor.  
 
MATERIALS AND METHODS 
All modeling and calculations were done in MATLAB (MATLAB Release 2010b, The MathWorks, Inc., Natick, 
Massachusetts, United States). 
The Basic Vascular Model 
Transfer function of the vascular pathway 
We previously introduced a model to address dispersion and delay of the CA profile when flowing from a main 
artery down to the lower levels of the vascular tree in the brain(17) [**]. This model is mainly based on a previously 
derived equation for describing the transfer function of a single vessel with laminar flow (3, 17). The transfer 
function is a function of 𝑡0𝑛, the time required for the fluid on the central axis of the tube to pass through the a 
vessel at the 𝑛th branching level: 
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ℎ𝑛(𝑡) =  � 0 𝑡 < 𝑡0𝑛2𝑡02
𝑡3
𝑡 ≥ 𝑡0𝑛
 𝑛 = 1,2, … , 6     (1) 
 
Where: 
   𝑡0𝑛 =  𝐷0𝑛𝑣0𝑛       (2) 
Here, 𝐷0𝑛 is the length and 𝑣0𝑛the maximum velocity of blood in the vessel (or the velocity along the central axis) at 
the 𝑛th level. The interesting point about this transfer function is that it can describe each vessel segment based on 
only one parameter (𝑡0𝑛). This parameter is not related to the injection time of the contrast agent and based on 
Equation 2, depends only on the blood velocity in the vessel and its length. We will refer to 𝑡0𝑛 as the branch delay 
which is a characteristic of each branch, assuming that blood flow is constant. We selected the maximum value of 
n=6 based on the study done by Wright et al where they measured the number of arterial branching levels in the 
different brain regions using magnetic resonance angiography (18). 
 
Under certain assumptions, the delay time, 𝑡0𝑛of each segment in the vascular tree can be considered equal [**] and 
in this case the transfer function of all the sequential branches can be considered identical. In this case the 
parametric equation of the transfer function from the opening of a main branch to the end of one of the sub-branches 
at the nth level of vascular tree can be expressed as: 
 
 ℎ(𝑡)1 𝑡𝑜 𝑛 = 𝑔 × [ℎ(𝑡)1]∗𝑛    (3) 
 
Where “∗ 𝑛” denotes 𝑛 repeated convolutions. Here 𝑔 is a gain factor compensating for the fractional volume of the 
vessels in the tissue.   
By sampling the CA profile from a voxel in the DCE image series, and also by sampling the AIF in a voxel 
representing the circle of Willis, we can write the following equation: 
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 𝐴𝐼𝐹𝐿(𝑡) =  ℎ(𝑡)1 𝑡𝑜 𝑛 ∗ 𝐴𝐼𝐹(𝑡)     (4) 
 
𝐴𝐼𝐹𝐿(𝑡) is the local AIF in the tissue. If the vessels are intact and do not have CA leakage, the CA profile sampled 
from a voxel in the DCE images can represent the 𝐴𝐼𝐹𝐿(𝑡).It should be noted that in this equation, the effects of the 
capillaries on dispersing the AIF has not been considered. To find the transfer function that can best describe the 
relation between the AIF and 𝐴𝐼𝐹𝐿(𝑡) for each voxel in the image, we developed a procedure based on the Nelder-
Mead simplex search method of Lagarias et al.(19) as a non-linear fitting method with the sum of squared errors as 
the cost function, along with Akaike Information Criterion (AIC) (20) to find the best configuration of the transfer 
function (based on the number of branching layers, n) that can transform the AIF to the 𝐴𝐼𝐹𝐿(𝑡). Since initially it is 
not known that the selected voxel belongs to which branching level of the vascular tree, the fitting procedure is 
repeated separately for six configurations of one to six layers of branching, to find the following set of parameters 
for the transfer function for each configuration:  
 [𝑔, 𝑡01]       (5) 
 
After finding the best fit transfer function for each configuration of the vascular tree, using the fitting residual 
values, the best model is selected using the AIC to represent the transfer function that transfers the AIF to the 
selected 𝐴𝐼𝐹𝐿(𝑡)[**] 
 
The model described above (Basic Vascular Model or BVM) has been designed to explain dispersion and delay of 
the AIF in the vascular tree with no extravasation in any of the vessels. As we will explain in the following sections, 
the model in its current form will not be able to explain the profile of the CA concentration when the signal is 
sampled from areas with leaky vessels. 
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 Extending the Basic Vascular Model 
When the tissue concentration signal is sampled from voxels in image areas containing vessels with no leakage, the 
signal mainly represents the CA concentration profile in the intravascular space. This profile is generally a dispersed 
form of the AIF in major vessels; however, when the CA leaks into the extravascular space, the sampled tissue 
concentration signal will follow a different trend. Based on this observation, to address the changes of the CA 
profile in areas with leaky vasculature and to find a more accurate estimation of the intravascular (plasma) CA 
concentration profile in these vessels, we modified the BVM to include effects of leakage of the CA to the 
extravascular space.  
Adding Permeability Parameters to the Basic Vascular Model  
One of the models describing tracer kinetics is the Extended Tofts Model or Standard Model (SM). According to the 
SM which is a two compartmental model (12, 21), the relationship between 𝐶𝑡(𝑡) (tissue concentration profile of the 
CA) and 𝐶𝑝(𝑡) (plasma concentration profile of the CA) can be described follows:  
 
𝐶𝑡(𝑡) =  𝐾𝑡𝑟𝑎𝑛𝑠 ∫ 𝑒−𝑘𝑏(𝑡−𝜏)𝐶𝑝(𝜏)𝑑𝜏𝑡0 + 𝑣𝑝𝐶𝑝(𝑡)    (6) 
 
In this equation, the tissue concentration of CA, 𝐶𝑡(𝑡) is composed of two main components: The first term on the 
right, 𝐾𝑡𝑟𝑎𝑛𝑠 ∫ 𝑒−𝑘𝑏(𝑡−𝜏)𝐶𝑝(𝜏)𝑑𝜏𝑡0  represents the component of the signal that is due to leakage of the CA to the 
extravascular space and is dependent on the forward (Ktrans) and inverse (kb) transfer rate constants. The second 
term,𝑣𝑝𝐶𝑝(𝑡) basically represents the time trace of the plasma CA concentration in the vessels that feed the tissue 
from which 𝐶𝑡(𝑡) is being sampled.  Depending on the type of the vasculature leakage, some of the permeability 
parameters may not be taken into account and Equation 6 may follow different models of vascular extravasation as 
described below (9, 22):  
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Model I:  Impermeable vasculature where the Blood Brain Barrier is intact (Ktrans = 0, kb= 0, vp≠ 0). 
Model II:  Moderate influx which is observed as leakage without efflux (Ktrans ≠ 0, kb= 0, vp≠ 0). 
Model III:  Fast leakage which leads to bidirectional exchange (Ktrans ≠ 0, kb≠0, vp≠ 0). 
  
Figure 1 shows a schematic diagram of the signal components of the extended Tofts model and their relation. 
𝐴𝐼𝐹(𝑡) is the CA profile sampled at the location of one of the major arteries. The cube in this figure represents an 
imaginary voxel in the image where the tissue CA concentration profile 𝐶𝑡(𝑡), is being sampled from. 𝐶𝑝(𝑡) is the 
plasma CA concentration in the vessel (or vessels) feeding the tissue in the voxel.  
 
As we noted in the introduction section, in conventional methods of calculating the permeability parameters using 
the pharmacokinetic model, for the profile of 𝐶𝑝(𝑡), the CA profile sampled from one of the major arteries (in the 
image) or even veins (such as the superior sagittal sinus) is usually used; however, this is not a correct representative 
of the CA profile in tissue since it does not address dispersion of the CA profile at different levels of the vascular 
tree and can lead to biased estimates of the permeability parameters. In image areas with non-leaky vessels, the 
sampled profile basically represents only the intravascular CA concentration which can be described with the BVM 
[**]. To find an equation for describing the intravascular CA concentration profile in leaky vessels, we added a new 
feature to the vascular transfer function that we defined by Equation 3. If in Equation 6 we replace the plasma CA 
concentration profile, 𝐶𝑝(𝑡) with the local interpretation of the AIF in tissue, the pharmacokinetic model can be 
written as: 
 
𝐶𝑡(𝑡) =  𝐾𝑡𝑟𝑎𝑛𝑠𝑣𝑝 ∫ 𝑒−𝑘𝑏(𝑡−𝜏)𝐴𝐼𝐹𝐿(𝜏)𝑑𝜏𝑡0 + 𝐴𝐼𝐹𝐿(𝑡) =  𝐾𝑡𝑟𝑎𝑛𝑠𝑣𝑝 (𝑒−𝑘𝑏𝑡 ∗ 𝐴𝐼𝐹𝐿(𝑡)) + 𝐴𝐼𝐹𝐿(𝑡)   
 (7) 
 
And by replacing 𝐴𝐼𝐹𝐿(𝑡) from Equation 4 we have: 
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 𝐶𝑡(𝑡) =  𝐾𝑡𝑟𝑎𝑛𝑠𝑣𝑝 (𝑒−𝑘𝑏𝑡 ∗ 𝐴𝐼𝐹(𝑡) ∗ ℎ(𝑡)1 𝑡𝑜 𝑛) + 𝐴𝐼𝐹(𝑡) ∗ ℎ(𝑡)1 𝑡𝑜 𝑛   (8) 
 
or 
 𝐶𝑡(𝑡) = 𝐴𝐼𝐹(𝑡) ∗ �ℎ(𝑡)1 𝑡𝑜 𝑛 ∗ �𝐾𝑡𝑟𝑎𝑛𝑠𝑣𝑝 𝑒−𝑘𝑏𝑡 + 𝛿(𝑡)�� = 𝐴𝐼𝐹(𝑡) ∗ ℎ𝐸(𝑡)  (9) 
 
Where  
ℎ𝐸(𝑡) =  ℎ(𝑡)1 𝑡𝑜 𝑛 ∗ �𝐾𝑡𝑟𝑎𝑛𝑠𝑣𝑝 𝑒−𝑘𝑏𝑡 + 𝛿(𝑡)�     (10) 
 
The transfer function ℎ𝐸(𝑡), describes transformation of the AIF profile to the measured tissue concentration signal 
at different locations of the vascular structure, with or without leakage of the vessels. In the case where the vessels 
are intact (non-leaky), Ktrans will be zero and the measured signal will be basically the intravascular plasma 
concentration of the CA in the tissue which can be described by convolving the AIF with ℎ(𝑡)1 𝑡𝑜 𝑛. In the case 
where the vessels are leaky, 𝐶𝑡(𝑡) is the superposition of the intravascular and extravascular components of the 
signal which are the two main components of this equation. 
 
To find the best function that transfers the AIF to the tissue concentration signal, in addition to the six configurations 
of the vascular tree (as in the BVM), three configurations of the SM (9, 22) (Models I, II and III) are also 
considered. Therefore for each signal, 18 different combinations of the transfer function are studied and using the 
fitting residues for each, the best transfer function describing transformation of the AIF to the tissue CA 
concentration profile is selected using the AIC. After finding the curve that best fits to the sampled signal, using the 
parameters found in the fitting procedure and also the two main components of this transfer function, the transfer 
functions describing the extravascular and intravascular components of the tissue concentration signal can be 
This article is protected by copyright. All rights reserved.
constructed and by convolving them with the AIF profile, each can be described as below: 
 
𝐶𝑡
𝐼(𝑡) = 𝐴𝐼𝐹(𝑡) ∗ ℎ(𝑡)𝑒𝑠𝑡        (11) 
𝐶𝑡
𝐸(𝑡) = 𝐾𝑡𝑟𝑎𝑛𝑠
𝑣𝑝
𝑒−𝑘𝑏𝑡 ∗ 𝐴𝐼𝐹(𝑡) ∗ ℎ(𝑡)𝑒𝑠𝑡      (12) 
 
Here 𝐶𝑡𝐼(𝑡) and 𝐶𝑡𝐸(𝑡) are the intravascular and extravascular components of the tissue CA concentration profile and 
ℎ(𝑡)𝑒𝑠𝑡 is the estimated vascular transfer function. 
 
Subjects 
Three treatment naïve patients with Glioblastoma Multiforme (GBM) were scanned using the procedure described 
below. The study was approved by the Henry Ford Health System Institutional Review Board and written informed 
consent was obtained from all subjects. 
 
DCE-MR Image Acquisition: 
DCE-MR image acquisition was performed on a 3T GE Excite HD MR system (GE Healthcare, Waukesha WI) 
using a standard eight-channel phased-array RF coil. Before CA administration, T1 mapping was obtained using 
DESPOT1 (23). With TE/TR = 0.84/5.8ms, 256×256 matrix size, 240 mm FOV, sixteen slices with 5 mm thickness 
and six  flip angles of 2°, 5°, 10°, 15°, 20°, and 25°. These images were used to create the pre-contrast T1 maps that 
were used as the baseline values for the 3D Spoiled Gradient Echo (SPGRE) DCE-T1 procedure (9). The 3D 
SPGRE DCE-T1 sequence included 70 image volumes acquired 5.9s apart, all with a 20° flip angle, TE/TR = 
0.84/5.8 ms, 256×256 matrix size, 240 mm FOV, sixteen slices with 5 mm thickness. Total data acquisition was 6.8 
min. Contrast agent (Magnevist; Bayer Healthcare Pharmaceuticals, Wayne, NJ) was administered intravenously by 
power injection 20s after the start of the DCE-T1 sequence, at a dose of 0.1 mmol/kg with a rate of 4 mL/s.  
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It has been shown that changes in the relaxivity (∆R1) are linearly related to contrast agent concentration in tissue 
(24, 25); we previously derived an equation for extracting ∆R1 signals from T1-weighted SPGRE MRI data (9). If 
TE is selected such that TE << T2*, the effects of T2* in the ∆R1 calculated from the SPGRE DCE-T1 data can be 
minimized (9) which is the condition we had for acquiring our DCE-T1 images. By applying this equation to our 
DCE-T1 data we produced the ∆R1 maps for this image sequence. The voxelwise ∆R1 signals in these images were 
used for estimation of the permeability parameters using the SM. To adjust the equations for DCE-MR applications, 
we replace 𝐶𝑡(𝑡) with  (1 − 𝐻𝑐𝑡)𝛥𝑅1𝑡(𝑡) and 𝐴𝐼𝐹(𝑡) with ∆𝑅1𝑎(𝑡) in equation 9: 
 (1 − 𝐻𝑐𝑡)𝛥𝑅1𝑡(𝑡) = ∆𝑅1𝑎(𝑡) ∗ ℎ𝐸(𝑡)     (13) 
 
 
Comparison of Performance of the BVM and the Extended Model in Normal and Leaky vessels 
To compare the performance of the BVM with its extended form for describing the CA concentration profile in 
brain areas with leaky or non-leaky vessels, we studied the tissue CA concentration signals sampled from two 
regions of the brain in a patient with GBM: One from the normal tissue and the other from the tumor area. For each 
model, based on the procedure explained in the methods section, we separately used the BVM and the extended 
model to find the best transfer function describing the transformation of the AIF to the CA concentration profile in 
each of these regions. 
 
Applying the Extended Model to DCE-T1 Images for Estimation of the Permeability Parameters 
When using the extended model for estimation of the transfer function, for each voxel in the image, in addition to 
the parameters describing the vascular structure connecting the major artery and the vessels passing through that 
voxel, the permeability parameters can also directly be estimated as a byproduct of the method. Depending on the 
model of leakiness that is being considered, at each branching level, the transfer function can have one (vp), two (vp, 
Ktrans) or three (vp, Ktrans, Kb) parameters to represent one of the three configurations of the SM.  After estimating all 
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18 transfer functions based on the fitting procedure and selecting the best fitted model, the permeability parameters 
can be estimated using the parameters of the best fit model.  
 
We previously reported another method that we had established for estimating permeability parameters (9) in DCE-
T1 images. This method was also based on finding the best set of permeability parameters describing the three 
configurations of the SM. In this method, initially for each configuration, the best set of parameters that related the 
global AIF to the tissue CA concentration in each voxel was estimated using the simplex method. Next, using the F-
test (26), the best configuration was selected and the parameters satisfying that configuration of the SM were 
selected as the permeability parameters for that voxel. The difference between this method and using the extended 
model is basically using the global AIF vs. the local AIF for solving the SM or Tofts equation. To compare the 
results, and to evaluate the results of employing the local AIF for estimating permeability parameters, we estimated 
the permeability parameter maps from the DCE-T1 images of the brain of a patient with GBM, using both methods.  
 
Simulation Study 
One of our main goals for developing the vascular model is to estimate the permeability parameters more accurately. 
We hypothesized that by employing the local AIF and using that for solving the pharmacokinetic model, we will be 
able to find more accurate estimates of the permeability parameters.  To test this hypothesis, we simulated the three 
models of vascular leakage at different branching levels of the vessels and compared the estimated values of the 
permeability parameters when using the global AIF vs. the local AIF found by the vascular model. Our assumption 
was that the artery or arteriole that feeds the capillary bed can be from any of the six branching levels. Although this 
is not necessarily true, we did this to make our simulation more robust. 
 
In the first step, using the AIF sampled from the circle of Willis in the ΔR1 image series estimated from the DCE 
MRI series of a human subject (with image acquisition parameters described in the previous section), we simulated 
curves of the dispersed AIF at six levels of the vascular system using our vascular model with values close to those 
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in the arteries of the human brain. This provided the dispersed and delayed CA concentration profile at each of these 
layers. For model I, which is considered to be the model with no vascular leakage, the only parameter that we 
accounted for was the fractional plasma volume, vp. Using four different values of vp (0.01, 0.02, 0.04 and 0.1), 
tissue concentration signals were simulated at each level of the vascular branching structure. For simulating the 
signals for Model II, the forward transfer rate constant (Ktrans) was added to the equation to simulate leakage of the 
vessels. We did the simulation for a fixed value of the fractional plasma volume (vp = 0.01) and two values of the 
forward transvascular transfer rate (Ktrans= 0.001 (1/min) and 0.005 (1/min)). And finally, the tissue concentration 
signal was simulated using model III of the Pharmacokinetic model in which a third parameter, Kb was added. 
Similar to the other two models, we estimated these three parameters using the two methods and compared the 
results. The simulation was done using Ktrans = 0.005 and vp = 0.01 and two values for Kb (0.2 and 0.5).  
 
RESULTS 
Applying the BVM to MRI data 
Figure 2-a shows one slice of a DCE-T1 image from a patient with Glioblastoma Multiforme after injection of the 
CA. Figure 2-b shows the CA concentration profile (𝛥𝑅1(𝑡))  sampled from the voxels in the circle of Willis (as 
marked in Figure 2-a) and Figure 2-c shows the CA profile from an ROI sampled from the normal white matter area. 
Using the procedure explained in the methods section, we found the best transfer function (based on the BVM) 
explaining the transformation of the AIF to this local AIF. By convolving the AIF in Figure 2-b with this transfer 
function, the bold curve in Figure 2-e is estimated.  To explore the performance of this model in other areas of the 
brain, we sampled a signal from an ROI in the tumor area as seen in Figure 1-a. The CA concentration profile 
sampled from this ROI can be seen in Figure 2-d. The tail of this profile does not follow the trend that is seen in the 
CA profile in the normal area. After applying the method above to this signal and finding the best fit, the bold curve 
in Figure 2-f is estimated. As seen here, the BVM can only describe changes in the CA profile in intact vessels with 
no leakage and in cases where leakage vascular exists, it does not perform correctly. 
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Applying the Extended Model to MRI data  
To test the extended model, we applied it to the CA concentration profile sampled from the tumor area (Figure 2-a). 
The bold curve in Figure 3-b shows the tissue CA concentration profile that was reconstructed by convolving the 
best selected transfer function with the AIF. As seen in this figure, this profile matches the original data very well. 
We applied the extended model to the CA profile sampled from the normal tissue and repeated the same procedure 
on it. Figure 3-a shows the reconstructed profile. This profile is the same as the profile found using the basic 
vascular model. Using the estimated parameters of the transfer function, the tissue concentration profile was 
decomposed into the intravascular and extravascular components. These can be seen in Figure 3-c and Figure 3-d. 
When the signal is sampled from the normal tissue, the extravascular component appears to be non-existent and is 
seen as a flat line. But for the signal sampled from the tumor area, these two components are separated as two 
different profiles: The intra-vascular signal and the extra-vascular signal representing leakage of the CA to the EES.  
 
We applied both models to all voxels in a slice of the DCE-T1 image series of the same patient. Figure 4 shows 
residual maps from the fitting procedure using the two models for different levels of the vascular tree. The residual 
values in the tumor area are much lower for the extended model which means that this model can explain the trend 
of the CA profile in the leaky vasculature areas much better than the BVM. Finding the best fit in the lower levels 
can be due to the tumor being fed through a major artery in the lower branching levels. 
 
Estimation of Permeability Parameters in DCE-MR Imaging Using the Extended Model 
Figures 5-a, 5-c and 5-e show the three permeability maps (vp, Ktrans, Kb) that were estimated by solving the 
pharmacokinetic model using the global AIF for the DCE-MR series of the slice shown in Figure 5-g. Figures 5-b, 
5-d and 5-f show the same maps that were estimated using the local AIF found by the extended model. As seen in 
the vp map, in the non-leaky areas the values found by the two methods are very close; however, the vp values in 
figure 5-a show lower values in the tumor area compared to Figure 5-b.  This can be interpreted as an 
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underestimation of the plasma volume fraction in leaky areas when the global AIF is used. The outcome of the 
simulation study described in the next section confirms these results. Comparison of the corresponding Ktrans and Kb 
maps when the extended model is used, show that the values of Ktrans and Kb when using the global AIF are both 
underestimated. The total time for processing one slice of the DCE-MR images was approximately 3 hours on an 
Intel Core i7, 2.70 GHz processor. This included 18 repetitions of the transfer function fitting algorithm for each 
voxel and finally selecting the best fit transfer function. 
Simulation Study 
In Figure 6 the results of estimating vp using the two methods are presented. The signals were simulated for four 
values of vp (0.01, 0.02, 0.04 and 0.1). The observation in all these graphs is that when the global AIF is used, 
starting from the first level of vascular branching, the value of vp gets underestimated and the gap between the 
estimated value and the nominal value increases as the tissue concentration signal gets more dispersed. But the 
values estimated by the model corrected local AIF remain very close to the nominal value at all levels of the 
vascular branching.  
 
The plots in Figure 7 show the estimated values of Ktrans and vp in the case of simulating model II, calculated using 
the global AIF and the model corrected local AIF, assuming that they are sampled from six different levels of the 
vascular tree. Figure 7-a and 7-b show the case where vp = 0.01 and Ktrans = 0.001 (1/min) and Figures7-c and 7-d 
represent vp=0.01 and Ktrans = 0.005 (1/min). As seen here, in both configurations, the Ktrans values found using the 
global AIF are overestimated at all branching levels and as the vascular levels increase, this value increases as well. 
In the case of the estimated vp (similar to the case of the first configuration of the Pharmacokinetic model) when 
using the global AIF, the fractional plasma volume is underestimated starting from the first level and is 
underestimated by about 80% the nominal value when it gets to the last level. In the case of using the extended 
model, the estimated value of vp is always accurate. 
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The graphs comparing the estimated values of Ktrans, Kb and vp, using the two AIFs for two sets of Model III 
simulated signals are plotted in Figure 8.  As seen in both signal sets, the value of vp, Ktrans and Kb estimated by the 
local AIF is the same as the nominal value. In this case of using the global AIF, the value of Ktrans can be 
overestimated as much as 20 times and Kb and high as 6 times the nominal value. 
 
 
DISCUSSION AND CONCLUSION 
We introduced a model of the brain vascular system that explains dispersion and delay of the AIF at different levels 
of the vascular structure, combined with the effects of extravasation of the CA to the extravascular space. This 
model is an extension of a previous model of the vessels (BVM) which did not include effects of extravasation. The 
results of applying these models to DCE-T1 images of patients with GBM show that the extended vascular model is 
able to explain the CA concentration profile at different levels of the vascular tree in areas of the brain, with or 
without leakage of the vessels. Also simulation results showed that for solving the Tofts equation, if the local AIF 
provided by the vascular model is used instead of the global AIF, permeability parameters can be estimated more 
accurately.  
 
The advantage of using the vascular model for solving the pharmacokinetic model as described by Tofts equation is 
that it can provide an estimate the local AIF found in each voxel which can lead to more accurate estimation of the 
permeability parameters. One by-product of using this model is that it can be used for decomposing the tissue 
concentration signal of the CA into the intra and extra-vascular components which are basically the flow and 
leakage components of the signal. Extracting the extra-vascular component of the signal can lead to estimation of 
the permeability parameters with fewer data points and using shorter scan times. Overall, this model has the 
potential to address many open problems in DCE-MRI and DSC-MRI and also in DCE-CT applications where this 
model can be used for simultaneous measurement of permeability and perfusion parameters. It should be noted that 
although this model in its current form gives a reasonable estimate of the local AIF, a more complete model should 
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take into account the effects of the capillaries on the dispersion which can be added in future studies. However, the 
model in its current form is a big step forward towards finding less biased estimates of the permeability parameters. 
Another point is that in our model we selected the maximum number of branching levels as six levels; although 
there is the possibility of existence of branches having higher number of bifurcations, in such events, n = 6 would be 
selected as the best configuration of the function. One of the drawbacks of this method is the relatively long 
processing time due to the 18 configurations of the model that are being fit to the data. One solution to solving this 
would be to use adaptive models for this part of the methods.  
In the simulation study, although the full range of parameters was not considered, the results show that when the 
local AIF is used, the estimated parameters are less biased compared to the case of using the global AIF. Although 
in this study the transfer function based on the extended model was used for simulating the tissue concentration 
signals and for transforming the AIF, however, based on our model, we expect the simulated signals to be a 
reasonable estimation of the signals is real tissue. The accuracy of the results show the reliability of this model for 
estimating the permeability parameters by decomposing the tissue concentration signal to the intravascular and 
extravascular components which is the main advantage compared to using the global AIF. Comparing these 
simulation results with the results obtained from processing the DCE-MRI data from the tumor patients confirms 
that when the global AIF is used for solving the pharmacokinetic equation, the permeability parameters estimated in 
the tumor area are overestimated or underestimated with the same trend as the simulation study. These results 
confirm the findings by Fluckiger et al when they used a local AIF for measuring the permeability parameters (15). 
One issue with any suggested model in DCE studies is clinically validating the estimated parameters in the human 
brain (27). Although there have been attempts to address this issue by developing phantoms to simulate perfusion, 
most of these systems fail to establish and accurately replicate physiologically relevant capillary permeability and 
exchange performance. One approach to solving this problem has been using concepts of physics and transport 
phenomena for better understanding of contrast agent kinetics. In one approach, Peladeau-Pigeon and Coolens (27) 
used the results of a Computational Fluid Dynamics (CFD) simulation and DCE-CT data obtained from a flow 
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phantom to test Tofts (28) enhanced model and Fick’s principle (29) The phantom used in this study contained a 
single tube. Our simulation is a similar approach for simulating such a physical model; however, effects of 
dispersion due to vascular branching and flow have also been incorporated in our model. Although, validation of the 
results for in vivo human data is not possible, in the next step, to further investigate the accuracy of these results, 
these methods will be applied to DCE-T1 images of animals. Assessment of the accuracy of either method for 
estimating the permeability parameters can be investigated using methods such as histology or autoradiography; 
however, the results of the simulation study lean towards accuracy of the values found by the extended model. 
In conclusion, we have introduced a model of the brain vasculature that describes the flow of blood in the brain 
vessels and also leakage of the CA to the extracellular extravascular space. This model can be used to estimate the 
local AIF in brain areas with vessels with or without leakage of the CA. Our simulations show that using the local 
AIF estimated by this model for solving the SM can give less biased estimations of the permeability parameters 
compared to using the global AIF. Using this model on DCE-MR images of cerebral tumors for estimating the 
permeability parameters yielded similar results as the simulations. One application of this model can be 
simultaneous estimation of the intravascular component of the CA concentration signal and the permeability 
parameters in areas with vascular extravasation. To validate the accuracy of the method for estimating the 
permeability parameters, it should be applied to DCE images of animals. Further additions to this model can include 
effects of the capillaries on dispersion of the AIF so that this model can be used for more accurate estimation of 
perfusion parameters in DCE-CT and DSC-MR images. 
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Figure 1.Schematic diagram showing the main components of the pharmacokinetic model and their location. AIF(t) is the CA 
profile sampled at the location of one of the major arteries. The cube in this figure represents an imaginary voxel in the 
image where the tissue CA concentration profile, Ct(t), is being sampled from.  Cp(t) is assumed to be the plasma CA 
concentration in the vessel (or vessels) feeding the tissue in the voxel. 
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Figure 2. (a) One slice of a post contrast injection DCE-MRI image from a patient with Glioblastoma Multiforme with three ROIs from a major 
artery (AIF), normal tissue (LAIF(N)) and the tumor area (LAIF(T)). The CA profile sampled from the major artery (b) normal tissue (c, non-
leaky vasculature) and the tumor area (d, leaky vasculature) from the DCE-MR image series. Using our vascular model, the transfer function 
that gave the best fit for each of the two CA profiles and the resulting local AIF was found.  As seen here, in the case of non-leaky 
vasculature, after reconstruction using the best fit transfer function, the resulting local AIF can give a good estimation of the signal sampled 
from the tissue (e). But in the case of the signal sampled from the tumor area (f), the best fit signal cannot follow the trend of the AIF and 
the best fit model is erroneously selected as the sixth level to minimize the residual error of the fitting procedure. The Sum of Squared Errors 
(SSE) for the fitted curves in (e) and (f) are 4.86 E-8 and 9.29 E-006 respectively. 
 
Figure 3. The profiles representing the tissue CA concentration (thin line) and the reconstructed profile after fitting and model selection 
(bold line) from (a) the normal tissue and (b) the tumor area as described in Figure 2. (c) and (d) show  intra-vascular  and extra-vascular 
components of the reconstructed tissue concentration profiles, based on the decomposition done by the Extended Vascular Model. As seen 
here, in the case where the signal sampled from the normal tissue (c), the extra-vascular component is a flat line, indicating no leakage to 
the extra-vascular space. But when the signal in sampled from the tumor (d) the intra-vascular and extra-vascular components are separated 
which can indicate the flow or extravasation properties of the vessels in the sampled region independently. The Sum of Squared Errors (SSE) 
for the fitted curves in (a) and (b) are 4.86 E-8 and 2.98 E-7 respectively. 
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Figure 4. Maps of the fitting residual values using the BVM and the Extended Model (EM) in a set of DCE MR Images. Every 
voxel in each map represents the residue of the best fit function at each branching level of the vascular structure. For better 
representation of these maps, they have been scaled to 𝒍𝒐𝒈 (𝟏𝟎𝟖 𝑺𝑺𝑬) which 𝑺𝑺𝑬 is the Sum of Squared Errors of the fitting 
process. In areas of the brain outside the tumor, the residual values are almost identical for the EVM and BVM at each 
branching level which indicates that the EVM can explain dispersion and delay of the AIF in non-leaky vessels similar to the 
BVM. As seen here, the residual values in the tumor area are much lower for the EVM which means that this model can 
explain the trend of the CA profile in the leaky vasculature areas much better than the BVM. Finding the best fit for the 
tumor at the 4th level can be due to the tumor being fed through a vessel at the 4th branching level. 
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Figure 5 (a, c and e) The three permeability maps (vp, K
trans, Kb) estimated by solving the pharmacokinetic model using the 
global AIF for the DCE-MR series of the slice shown in (g). (b, d and f) permeability maps estimated using the Local AIF found 
by the vascular model. (h) Model selection map estimated using the residual sum of squares from the fitting procedure and 
finding the minimum AIC. (i) The mean, standard deviation, minimum and maximum values of vp, K
trans and Kb measured in 
the voxels representing the tumor. 
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Figure 6. (a) The vp values estimated by solving the PKM equation using the global AIF and local AIF estimated by the vascular 
model. When the model corrected local AIF is used, the estimated values of vp is much closer to the nominal value compared 
to using the global AIF which leads to underestimation of vp. (b)-(d) show the estimated values of vp for simulating a 
fractional plasma volume of 0.02, 0.04 and 0.1 
 
  
This article is protected by copyright. All rights reserved.
 Figure 7. Estimated values of Ktrans and vp calculated by solving the Pharmacokinetic model using the global AIF and the local 
AIF estimated by the vascular model for simulated signals. These signals were created assuming that they are sampled from 
six different levels of the vascular tree. Also, leakage was added to the vessels based on the second configuration of the 
pharmacokinetic model where only Ktrans and vp exist in the equation. Figures (a) and (b) show the case where vp = 0.01 and 
Ktrans = 0.001 (1/min) and (c) and (d) represent vp=0.01 and K
trans = 0.005 (1/min). As seen here, in both configurations, the 
Ktrans values found using the global AIF are over estimated at all branching levels and as the vascular levels increase, this 
value increases as well. In the case of Ktrans = 0.001, the over estimation is about 9 times the nominal value and in the case of 
Ktrans = 0.005, this is about 3 times. In contrast, for the case of using the vascular model, the estimated value of Ktrans is equal 
to the nominal value. In the case of vp, similar to the case of the first configuration of the Pharmacokinetic model, in the case 
of using the global AIF, the fractional plasma volume is underestimated from the first level and is underestimated by about 
half the nominal value. In the case of using the local AIF, the estimated value of vp is always accurate. 
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Figure 8. Estimated values of vp, K
trans and Kb, using the PKM and global AIF vs.  The local AIF corrected by the vascular model. 
The curves on the left (a, d, f) represent the case where Kb = 0.2 and the curves on the right represent Kb = 0.5. In both cases 
Ktrans = 0.005 and vp = 0.01. As seen in both cases, the value of vp estimated by vascular model is almost the same as the 
nominal value. The values of Ktrans and Kb are estimated close to the nominal value and even though at some of the branching 
levels they deviate from that value but it is much less than the case of the estimates done using the AIF.  In this case, the 
value of Ktrans can be overestimated as much as 20 times and Kb and high as 6 times the nominal value. 
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An Extended Vascular Model for Less Biased Estimation of Permeability Parameters in 
DCE-T1 Images 
 
Siamak P. Nejad-Davarani* , Hassan Bagher-Ebadian, James R. Ewing, Douglas C. Noll, Tom Mikkelsen, Michael 
Chopp, Quan Jiang 
 
We have introduced a model of the brain vascular system for simultaneously describing blood flow and contrast 
agent extravasation to the extravascular extracellular space, to be used for estimating the local arterial input function 
(AIF) and permeability parameters. Simulations show that using this model-corrected local AIF instead of the global 
AIF can lead to less biased estimates of the permeability parameters in pharmacokinetic models. Testing the two 
AIFs on DCE-T1 images of cerebral tumors showed similar trends in the estimated values of the permeability 
parameters as the simulated signals. 
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